title: Selective LOXL2 inhibition: potent antifibrotic effects in ongoing fibrosis and fibrosis regression.
authors.affiliation: Department of Internal Medicine I, University of Bonn, Bonn, Germany.|Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, USA.
authors.forename: Fernando
authors.initials: F
authors.lastname: Magdaleno
authors.affiliation: Department of Internal Medicine I, University of Bonn, Bonn, Germany.|Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, Odense, Denmark.|European Foundation for the Study of Chronic Liver Failure, Travessera de Gràcia, Barcelona, Spain.
authors.forename: Jonel
authors.initials: J
authors.lastname: Trebicka
mesh_terms: D005355:Fibrosis; D006801:Humans; D008103:Liver Cirrhosis
keywords: EXTRACELLULAR MATRIX; FIBROSIS; LIVER CIRRHOSIS